Literature DB >> 25814141

Caspase-8 Deficiency Presenting as Late-Onset Multi-Organ Lymphocytic Infiltration with Granulomas in two Adult Siblings.

Julie Niemela1, Hye Sun Kuehn, Corin Kelly, Mingchang Zhang, Joie Davies, Jose Melendez, Jennifer Dreiling, David Kleiner, Katherine Calvo, João B Oliveira, Sergio D Rosenzweig.   

Abstract

Caspase-8 deficiency (CED) was originally described in 2002 in two pediatric patients presenting with clinical manifestations resembling autoimmune lymphoproliferative syndrome (ALPS) accompanied by infections, and T, B and NK cell defects. Since then, no new CED patients were published. Here we report two adult siblings (Pt1 and Pt2) presenting in their late thirties with pulmonary hypertension leading to lung transplant (Pt1), and a complex neurological disease leading to multiple cranial nerves palsies (Pt2) as their main manifestations. A thorough clinical and immunological evaluation was performed at the Primary Immunodeficiency Clinic at NIH, followed by whole exome sequencing. The patients had multiorgan lymphocytic infiltration and granulomas, as well as clinical signs of immune deficiency/ immune dysregulation. Both siblings carried homozygous mutations in CASP8, c.1096C > T, p.248R > W. This was the same mutation described on the previously published CED patients, to whom these new patients were likely distantly related. We report two new CED patients presenting during adulthood with life-threatening end-organ lymphocyte infiltrates affecting the lungs, liver, spleen, bone marrow and central nervous system. This phenotype broadens the clinical spectrum of manifestations associated with this disease and warrants the search of CASP8 mutations in other cohorts of patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25814141      PMCID: PMC4439260          DOI: 10.1007/s10875-015-0150-8

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  16 in total

Review 1.  Predicting the effects of amino acid substitutions on protein function.

Authors:  Pauline C Ng; Steven Henikoff
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

2.  Caspase-8 is essential for maintaining chromosomal stability and suppressing B-cell lymphomagenesis.

Authors:  Anne Hakem; Samah El Ghamrasni; Georges Maire; Benedicte Lemmers; Jana Karaskova; Andrea Jurisicova; Otto Sanchez; Jeremy Squire; Razqallah Hakem
Journal:  Blood       Date:  2012-02-16       Impact factor: 22.113

3.  Requirement for caspase-8 in NF-kappaB activation by antigen receptor.

Authors:  Helen Su; Nicolas Bidère; Lixin Zheng; Alan Cubre; Keiko Sakai; Janet Dale; Leonardo Salmena; Razqallah Hakem; Stephen Straus; Michael Lenardo
Journal:  Science       Date:  2005-03-04       Impact factor: 47.728

4.  Caspase-8 acts as a molecular rheostat to limit RIPK1- and MyD88-mediated dendritic cell activation.

Authors:  Carla M Cuda; Alexander V Misharin; Angelica K Gierut; Rana Saber; G Kenneth Haines; Jack Hutcheson; Stephen M Hedrick; Chandra Mohan; G Scott Budinger; Christian Stehlik; Harris Perlman
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

5.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

6.  Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4.

Authors:  Hye Sun Kuehn; Weiming Ouyang; Bernice Lo; Elissa K Deenick; Julie E Niemela; Danielle T Avery; Jean-Nicolas Schickel; Dat Q Tran; Jennifer Stoddard; Yu Zhang; David M Frucht; Bogdan Dumitriu; Phillip Scheinberg; Les R Folio; Cathleen A Frein; Susan Price; Christopher Koh; Theo Heller; Christine M Seroogy; Anna Huttenlocher; V Koneti Rao; Helen C Su; David Kleiner; Luigi D Notarangelo; Yajesh Rampertaap; Kenneth N Olivier; Joshua McElwee; Jason Hughes; Stefania Pittaluga; Joao B Oliveira; Eric Meffre; Thomas A Fleisher; Steven M Holland; Michael J Lenardo; Stuart G Tangye; Gulbu Uzel
Journal:  Science       Date:  2014-09-11       Impact factor: 47.728

7.  Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.

Authors:  Hyung J Chun; Lixin Zheng; Manzoor Ahmad; Jin Wang; Christina K Speirs; Richard M Siegel; Janet K Dale; Jennifer Puck; Joie Davis; Craig G Hall; Suzanne Skoda-Smith; T Prescott Atkinson; Stephen E Straus; Michael J Lenardo
Journal:  Nature       Date:  2002-09-26       Impact factor: 49.962

8.  Cartilage-hair hypoplasia--clinical manifestations in 108 Finnish patients.

Authors:  O Mäkitie; I Kaitila
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

9.  Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity.

Authors:  Leonardo Salmena; Benedicte Lemmers; Anne Hakem; Elzbieta Matysiak-Zablocki; Kiichi Murakami; P Y Billie Au; Donna M Berry; Laura Tamblyn; Amro Shehabeldin; Eva Migon; Andrew Wakeham; Denis Bouchard; Wen Chen Yeh; Jane C McGlade; Pamela S Ohashi; Razqallah Hakem
Journal:  Genes Dev       Date:  2003-03-21       Impact factor: 11.361

10.  A framework for variation discovery and genotyping using next-generation DNA sequencing data.

Authors:  Mark A DePristo; Eric Banks; Ryan Poplin; Kiran V Garimella; Jared R Maguire; Christopher Hartl; Anthony A Philippakis; Guillermo del Angel; Manuel A Rivas; Matt Hanna; Aaron McKenna; Tim J Fennell; Andrew M Kernytsky; Andrey Y Sivachenko; Kristian Cibulskis; Stacey B Gabriel; David Altshuler; Mark J Daly
Journal:  Nat Genet       Date:  2011-04-10       Impact factor: 38.330

View more
  9 in total

Review 1.  30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology.

Authors:  Qian Zhang; Michael J Lenardo; David Baltimore
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

2.  Lymphoproliferation, immunodeficiency and early-onset inflammatory bowel disease associated with a novel mutation in Caspase 8.

Authors:  Veronika Kanderova; Hana Grombirikova; Irena Zentsova; Kamila Reblova; Adam Klocperk; Martina Fejtkova; Marketa Bloomfield; Barbora Ravcukova; Tomas Kalina; Tomas Freiberger; Anna Sediva
Journal:  Haematologica       Date:  2018-10-18       Impact factor: 9.941

Review 3.  The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.

Authors:  Frédéric Rieux-Laucat; Aude Magérus-Chatinet; Bénédicte Neven
Journal:  J Clin Immunol       Date:  2018-06-17       Impact factor: 8.317

Review 4.  Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children.

Authors:  Lindsey A George; David T Teachey
Journal:  Paediatr Drugs       Date:  2016-08       Impact factor: 3.022

Review 5.  Dysregulation of Cell Death in Human Chronic Inflammation.

Authors:  Yue Li; Christoph Klein; Daniel Kotlarz
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-07-01       Impact factor: 9.708

6.  Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target.

Authors:  Lauren Mifflin; Dimitry Ofengeim; Junying Yuan
Journal:  Nat Rev Drug Discov       Date:  2020-07-15       Impact factor: 112.288

7.  Caspase-8 auto-cleavage regulates programmed cell death and collaborates with RIPK3/MLKL to prevent lymphopenia.

Authors:  Xiaoming Li; Fang Li; Xixi Zhang; Haiwei Zhang; Qun Zhao; Ming Li; Xiaoxia Wu; Lingxia Wang; Jianling Liu; Xuanhui Wu; Yangjing Ou; Mingyan Xing; Yue Zhang; Jiangshan Deng; Xiuzhe Wang; Yan Luo; Jinbao Li; Yuwu Zhao; Haibing Zhang
Journal:  Cell Death Differ       Date:  2022-01-21       Impact factor: 12.067

Review 8.  Multiple roles of caspase-8 in cell death, inflammation, and innate immunity.

Authors:  Pontus Orning; Egil Lien
Journal:  J Leukoc Biol       Date:  2020-06-12       Impact factor: 4.962

9.  Caspase-8 mutations associated with head and neck cancer differentially retain functional properties related to TRAIL-induced apoptosis and cytokine induction.

Authors:  Zhibin Cui; Hadas Dabas; Brandon C Leonard; Jamie V Shiah; Jennifer R Grandis; Daniel E Johnson
Journal:  Cell Death Dis       Date:  2021-08-06       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.